[Anti-endothelial cell antibodies in predicting early miscarriage]

Area of Science:

• Reproductive Immunology
• Obstetrics and Gynecology
• Clinical Diagnostics

Context:

• Early miscarriage affects a significant number of pregnancies.
• Identifying predictive markers for early miscarriage is crucial for clinical management.
• Anti-endothelial cell antibodies (AECA) have been investigated for their potential role in pregnancy complications.

Purpose:

• To investigate the clinical significance of anti-endothelial cell antibodies (AECA) in predicting early miscarriage.
• To analyze the association between AECA positivity, gravidity, immunoglobulin G levels, and early pregnancy loss.
• To evaluate the impact of AECA on fetal survival rates.

Summary:

• A study of 122 pregnant women found that higher gravidity, AECA positivity, and elevated immunoglobulin G levels were significant risk factors for early miscarriage.
• AECA-positive pregnant women exhibited a significantly lower fetal survival rate by 12 weeks of gestation compared to AECA-negative women.
• The findings suggest AECA is a novel predictive marker for early miscarriage.

Impact:

• Highlights AECA as a potential diagnostic tool for identifying pregnancies at risk of early miscarriage.
• Provides evidence for the role of immune factors in early pregnancy failure.
• Informs clinical practice regarding risk assessment and management of early pregnancy loss.